Skip to main content

Table 1 Patient characteristics

From: SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine

  

Number (n = 139)

  

Number

(n = 139)

Result

Positive

1 (0.72%)

Radiation

Technique

3D-CRT

30 (21.6%)

 

Negative

138 (99.3%)

 

VMAT

83 (59.7%)

    

SRS/SRT/SBRT

18 (13.0%)

Age

< 40

9 (6.5%)

 

Brachytherapy

5 (3.6%)

 

40–49

15 (10.8%)

 

Others

3 (2.2%)

 

50–59

32 (23.0%)

   
 

60–69

25 (18.0%)

Entity

Brain

13 (9.4%)

 

> 70

58 (41.7%)

 

Head & Neck

11 (8.0%)

    

Breast

36 (25.9%)

Gender

Male

65 (46.8%)

 

Gynaecological

12 (8.6%)

 

Female

74 (53.2%)

 

Lung

24 (17.3%)

    

Gastrointestinal

12 (8.6%)

    

Bladder

2 (1.4%)

Intention

Curative

95 (68.3%)

 

Prostate

17 (12.2%)

 

adjuvant

59 (42.4%)

 

Lymphoma

3 (2.2%)

 

definitive

36 (25.9%)

 

Sarcoma

4 (2.9%)

 

Palliative

44 (31.7%)

 

Melanoma

4 (2.9%)

    

Others

6 (4.3%)

  1. 3D-CRT 3D conformal radiation therapy, VMAT Volumetric-modulated arc therapy, SRS Stereotactic radiosurgery, SRT Stereotactic radiotherapy, SBRT Stereotactic body radiation therapy